Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Tosk: Flying through preclinical testing

Tosk is screening Drosophila melanogaster mutants that model human disease to identify small molecule candidates to treat cancer and neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease (AD), stroke, amyotrophic lateral sclerosis (ALS), and diabetic neuropathy. The company also uses its fly model system to screen compounds for toxicity and preclinical characteristics prior to clinical development.

"We have separate products but all are based on the same

Read the full 665 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers